Ganciclovir

tumor protein p53 ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29133879 Development of a genetic sensor that eliminates p53 deficient cells. 2017 Nov 13 1
2 26934443 Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53. 2016 Apr 5 5
3 27464624 Bifidobacterial recombinant thymidine kinase-ganciclovir gene therapy system induces FasL and TNFR2 mediated antitumor apoptosis in solid tumors. 2016 Jul 27 1
4 25217394 The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells. 2014 Sep 1
5 21946198 [DNA damage caused by suicide gene therapy system under Tet-On regulation in breast cancer cells]. 2011 Sep 2
6 22174876 Adenoviral vector driven by a minimal Rad51 promoter is selective for p53-deficient tumor cells. 2011 1
7 20187803 Selective suicide gene therapy of colon cancer cell lines exploiting fibroblast growth factor 18 promoter. 2010 Feb 1
8 20199127 Selective suicide gene therapy of colon cancer exploiting the urokinase plasminogen activator receptor promoter. 2010 Apr 1 2
9 16838851 Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus. 2006 2
10 15592511 Mechanisms of thymidine kinase/ganciclovir and cytosine deaminase/ 5-fluorocytosine suicide gene therapy-induced cell death in glioma cells. 2005 Feb 10 3
11 15804027 [The effects of HSV-tk suicide gene and wild-type p53 gene on pleomorphic adenoma cells of salivary gland]. 2005 Feb 1
12 15916863 The suppressed proliferation and premature senescence by ganciclovir in p53-mutated human non-small-lung cancer cells acquiring herpes simplex virus-thymidine kinase cDNA. 2005 4
13 16050136 Influence of p53 status on the HSV-Tk/GCV-induced bystander effect in a panel of human ovarian carcinoma cell lines. 2005 4
14 12869633 P53-dependent cell-killing by selective repression of thymidine kinase and reduced prodrug activation. 2003 Aug 4
15 11871818 A novel suicide gene therapy system for p53-mutated cells using a wild-type p53-specific promoter and Cre/loxP switch. 2002 1
16 11313826 Death receptor-independent cytochrome c release and caspase activation mediate thymidine kinase plus ganciclovir-mediated cytotoxicity in LN-18 and LN-229 human malignant glioma cells. 2001 Mar 1
17 11526536 Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro. 2001 Sep 3
18 11559571 Self-deleting suicide vectors (SDSV): selective killing of p53-deficient cancer cells. 2001 Sep 15 1
19 10866313 Mitochondrial amplification of death signals determines thymidine kinase/ganciclovir-triggered activation of apoptosis. 2000 Jun 15 3
20 10195885 Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer. 1999 Mar-Apr 3
21 10411938 Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. 1999 Jul 20 2
22 10628368 Differential efficacy of suicide gene therapy by herpes simplex virus-thymidine kinase gene reflects the status of p53 gene in human esophageal cancer cells. 1999 Sep-Oct 1
23 8700554 Ganciclovir-induced ablation non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis. 1996 Jul 4 2